Study familial hypertrophic cardiomyopathy using patient-specific induced pluripotent stem cells
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
AIMS: Familial hypertrophic cardiomyopathy (HCM) is one the most common heart disorders, with gene mutations in the cardiac sarcomere. Studying HCM with patient-specific induced pluripotent stem-cell (iPSC)-derived cardiomyocytes (CMs) would benefit the understanding of HCM mechanism, as well as the development of personalized therapeutic strategies. METHODS AND RESULTS: To investigate the molecular mechanism underlying the abnormal CM functions in HCM, we derived iPSCs from an HCM patient with a single missense mutation (Arginine442Glycine) in the MYH7 gene. CMs were next enriched from HCM and healthy iPSCs, followed with whole transcriptome sequencing and pathway enrichment analysis. A widespread increase of genes responsible for 'Cell Proliferation' was observed in HCM iPSC-CMs when compared with control iPSC-CMs. Additionally, HCM iPSC-CMs exhibited disorganized sarcomeres and electrophysiological irregularities. Furthermore, disease phenotypes of HCM iPSC-CMs were attenuated with pharmaceutical treatments. CONCLUSION: Overall, this study explored the possible patient-specific and mutation-specific disease mechanism of HCM, and demonstrates the potential of using HCM iPSC-CMs for future development of therapeutic strategies. Additionally, the whole methodology established in this study could be utilized to study mechanisms of other human-inherited heart diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![Figure 5 Analysis of calcium handling and ion channels. (A) Representative calcium transient optical mapping indicating irregular calcium transients in HCM iPSC-CMs (Red arrows). (B) Quantification of calcium irregularity in control and HCM iPSC-CMs (n = 30). (C) Representative calcium transient mapping showing elevated resting [Ca2+]i in HCM CMs. (D) Quantification of resting [Ca2+]i in control and HCM CMs (n = 51). (E) Representative image of calcium release in control and HCM CMs post caffeine (5 mM) treatment. (F) Quantification of relative Ca2+ storage in SR (n = 11 control, n = 9 HCM). (G) Quantification of calcium transient decay time in control and HCM CMs. (n = 48 control, n = 50 HCM, P = 2.05E-07). (H) Measurement of ICa followed depolarizing potentials of −130 to 50 mV in 10 mV increments (n = 6) and western blot of Cav1.2 in control and HCM CMs. (I) Measurement of Na+ current magnitudes followed depolarizing potentials of −130 to 50 mV in 10 mV increments (n = 31) and western blot of SCN5A in control and HCM CMs. (J) Measurement of outward K+ currents followed depolarizing potentials of −130 to 50 mV in 10 mV increments (n = 10) and western blot of Kv4.2 in control and HCM CMs. Current-to-Voltage (I–V) relationships were normalized with respect to cell capacitance. Error bars show SD. *P < 0.05. (Student's t-test).](https://figures.cochat.ai/paper-figures/6c60ef9d5df84001bc7c6486f90a430a/study-familial-hypertrophic-cardiomyopathy-using-patient-specific-induced-figure-5.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The physiological and genetic differences between human and animals leads to potential differences in terms of function, mechanisms, and signaling pathways [14,15].”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [15]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Research using iPSC-derived cardiomyocytes from a patient with a mutation in MYH7 recapitulated HCM phenotypes including enlarged cellular size, disrupted sarcomere structures, contractile arrhythmia, and dysregulation of Ca2+ cycling.”
From Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy (2022) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors
Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K., & Yamanaka, S. (2007) · Cell · doi:10.1016/j.cell.2007.11.019 · Cited by 20,221
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,116
A Calcineurin-Dependent Transcriptional Pathway for Cardiac Hypertrophy
Molkentin, J. D., Lu, J.-R., Antos, C. L., Markham, B., Richardson, J., Robbins, J., Grant, S. R., & Olson, E. N. (1998) · Cell · doi:10.1016/s0092-8674(00)81573-1 · Cited by 2,566
Structure and Regulation of Voltage-Gated Ca 2+ Channels
Catterall, W. A. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.521 · Cited by 2,344
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224 · cited 9×
“most common autosomal dominant cardiovascular disease, with a prevalence of 1:500.(1) The overall annual mortality rate of HCM is 1– 5%.”
BackgroundMethodInfluentialRNA-guided genetic silencing systems in bacteria and archaea
Wiedenheft, B., Sternberg, S. H., & Doudna, J. A. (2012) · Nature · doi:10.1038/nature10886 · Cited by 1,851
Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population
Yang, L., Soonpaa, M. H., Adler, E. D., Roepke, T. K., Kattman, S. J., Kennedy, M., Henckaerts, E., Bonham, K., Abbott, G. W., Linden, R. M., et al. (2008) · Nature · doi:10.1038/nature06894 · Cited by 1,389 · cited 2×
“iPSCs were differentiated into CMs using our previously established protocol.(12,13) The EBs were dissociated at around Day 24, seeded into 6-well plates and cultured as monolayers for additional 5 days.”
MethodSelf-citationCalcium Cycling and Signaling in Cardiac Myocytes
Bers, D. M. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100455 · Cited by 1,302
Patient-Specific Induced Pluripotent Stem-Cell Models for Long-QT Syndrome
Moretti, A., Bellin, M., Welling, A., Jung, C. B., Lam, J. T., Bott-Flügel, L., Dorn, T., Goedel, A., Höhnke, C., Hofmann, F., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0908679 · Cited by 1,251
Modelling the long QT syndrome with induced pluripotent stem cells
Itzhaki, I., Maizels, L., Huber, I., Zwi-Dantsis, L., Caspi, O., Winterstern, A., Feldman, O., Gepstein, A., Arbel, G., Hammerman, H., et al. (2011) · Nature · doi:10.1038/nature09747 · Cited by 1,049
Electrophysiological remodeling in hypertrophy and heart failure
Tomaselli, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00017-6 · Cited by 748
Genetics of Hypertrophic Cardiomyopathy After 20 Years
Maron, B. J., Maron, M. S., & Semsarian, C. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.02.068 · Cited by 701
Patient-specific induced pluripotent stem cells as a model for familial dilated cardiomyopathy
Sun, N., Yazawa, M., Liu, J., Han, L., Sanchez-Freire, V., Abilez, O. J., Navarrete, E. G., Hu, S., Wang, L., Lee, A., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3003552 · Cited by 696
Self-citationPatient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome
Carvajal-Vergara, X., Sevilla, A., D’Souza, S. L., Ang, Y.-S., Schaniel, C., Lee, D.-F., Yang, L., Kaplan, A. D., Adler, E. D., Rozov, R., et al. (2010) · Nature · doi:10.1038/nature09005 · Cited by 690 · cited 4×
“Both of them were generated and fully characterized as previously described.(7,13) Both control and HCM iPSCs were differentiated into CMs using our established method(13) (Supplementary material online, Video S1), which was modified from our previous cardiac differentiation protocol with human embryonic stem cells.”
BackgroundMethodResultInfluentialSelf-citationEarly afterdepolarizations: mechanism of induction and block. A role for L-type Ca2+ current.
January, C. T., & Riddle, J. M. (1989) · Circulation Research · doi:10.1161/01.res.64.5.977 · Cited by 673
Lan, F., Lee, A. S., Liang, P., Sanchez-Freire, V., Nguyen, P. K., Wang, L., Han, L., Yen, M., Wang, Y., Sun, N., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.10.010 · Cited by 667
Self-citationUeno, S., Weidinger, G., Osugi, T., Kohn, A. D., Golob, J. L., Pabon, L., Reinecke, H., Moon, R. T., & Murry, C. E. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702859104 · Cited by 613
Naito, A. T., Shiojima, I., Akazawa, H., Hidaka, K., Morisaki, T., Kikuchi, A., & Komuro, I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0605768103 · Cited by 480
The Molecular Genetic Basis for Hypertrophic Cardiomyopathy
Marian, A. J., & Roberts, R. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1340 · Cited by 438
Coppini, R., Ferrantini, C., Yao, L., Fan, P., Del Lungo, M., Stillitano, F., Sartiani, L., Tosi, B., Suffredini, S., Tesi, C., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.134932 · Cited by 421
Lavine, K. J., Yu, K., White, A. C., Zhang, X., Smith, C., Partanen, J., & Ornitz, D. M. (2005) · Developmental Cell · doi:10.1016/j.devcel.2004.12.002 · Cited by 392
Molecular Mechanisms of Inherited Cardiomyopathies
Fatkin, D., & Graham, R. M. (2002) · Physiological Reviews · doi:10.1152/physrev.00012.2002 · Cited by 326
THE GENETIC BASIS FOR CARDIAC REMODELING
Ahmad, F., Seidman, J. G., & Seidman, C. E. (2005) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.6.080604.162132 · Cited by 307
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
Semsarian, C., Ahmad, I., Giewat, M., Georgakopoulos, D., Schmitt, J. P., McConnell, B. K., Reiken, S. R., Mende, U., Marks, A. R., Kass, D. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14677 · Cited by 250
Mechanisms of disease: hypertrophic cardiomyopathy
Frey, N., Luedde, M., & Katus, H. A. (2012) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2011.159 · Cited by 235
The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model
Semsarian, C., Ahmad, I., Giewat, M., Georgakopoulos, D., Schmitt, J. P., McConnell, B. K., Reiken, S., Mende, U., Marks, A. R., Kass, D. A., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214677 · Cited by 235
Therapeutic potential for HDAC inhibitors in the heart
McKinsey, T. A. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134712 · Cited by 230
Contraction-Induced Cell Wounding and Release of Fibroblast Growth Factor in Heart
Clarke, M. S. F., Caldwell, R. W., Chiao, H., Miyake, K., & McNeil, P. L. (1995) · Circulation Research · doi:10.1161/01.res.76.6.927 · Cited by 207
WNT Signaling in Adult Cardiac Hypertrophy and Remodeling: Lessons Learned From Cardiac Development
Bergmann, M. W. (2010) · Circulation Research · doi:10.1161/circresaha.110.223768 · Cited by 207
Friddle, C. J., Koga, T., Rubin, E. M., & Bristow, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100127897 · Cited by 201
Moore, J. R., Leinwand, L., & Warshaw, D. M. (2012) · Circulation Research · doi:10.1161/circresaha.110.223842 · Cited by 176
Knollmann, B. C., Kirchhof, P., Sirenko, S. G., Degen, H., Greene, A. E., Schober, T., Mackow, J. C., Fabritz, L., Potter, J. D., & Morad, M. (2003) · Circulation Research · doi:10.1161/01.res.0000059562.91384.1a · Cited by 165
Modifier genes for hypertrophic cardiomyopathy
Marian, A. J. (2002) · Current Opinion in Cardiology · doi:10.1097/00001573-200205000-00006 · Cited by 161
Kaye, D., Pimental, D., Prasad, S., Mäki, T., Berger, H. J., McNeil, P. L., Smith, T. W., & Kelly, R. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118414 · Cited by 149
Calcium current is increased in isolated adult myocytes from hypertrophied rat myocardium.
Keung, E. C. (1989) · Circulation Research · doi:10.1161/01.res.64.4.753 · Cited by 137
Pasumarthi, K. B. S., Kardami, E., & Cattini, P. A. (1996) · Circulation Research · doi:10.1161/01.res.78.1.126 · Cited by 122
Roles and Targets of Class I and IIa Histone Deacetylases in Cardiac Hypertrophy
Kee, H. J., & Kook, H. (2011) · BioMed Research International · doi:10.1155/2011/928326 · Cited by 109
Bogue, C. W., Ganea, G. R., Sturm, E., Iannucci, R., & Jacobs, H. C. (2000) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1059>3.0.co;2-# · Cited by 93
High-purity enrichment of functional cardiovascular cells from human iPS cells
Lin, B., Kim, J. K., Li, Y., Pan, H., Carvajal‐Vergara, X., Salama, G., Cheng, T., Li, Y., Lo, C. W. Y., & Yang, L. (2012) · Cardiovascular Research · doi:10.1093/cvr/cvs185 · Cited by 90
Self-citationSomura, F., Izawa, H., Iwase, M., Takeichi, Y., Ishiki, R., Nishizawa, T., Noda, A., Nagata, K., Yamada, Y., & Yokota, M. (2001) · Circulation · doi:10.1161/hc3101.093869 · Cited by 87
CXCL12-CXCR4 Promotes Proliferation and Invasion of Pancreatic Cancer Cells
Shen, B., Zheng, M.-Q., Lu, J., Jiang, Q., Wang, T.-H., & Huang, X. (2013) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2013.14.9.5403 · Cited by 73
Regulation of proliferation of the fetal myocardium
Armstrong, M. T., Lee, D. Y., & Armstrong, P. B. (2000) · Developmental Dynamics · doi:10.1002/1097-0177(2000)9999:9999<::aid-dvdy1049>3.3.co;2-s · Cited by 67
SDF1α/CXCR4 signaling stimulates β-catenin transcriptional activity in rat neural progenitors
Luo, Y., Cai, J., Xue, H., Mattson, M. P., & Rao, M. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.01.024 · Cited by 53
Dong, L.-L., Liu, L., Ma, C.-H., Li, J.-S., Du, C., XU, S., Han, L.-H., Li, L., & Wang, X.-W. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2012.30 · Cited by 48
Self-citationThe Biology and Therapeutic Implications of HDACs in the Heart
McKinsey, T. A. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-21631-2_4 · Cited by 41
Thievessen, I., Seifert, H.-H., Swiatkowski, S., Florl, A. R., & Schulz, W. A. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601031 · Cited by 41
FGF Induces Hypertrophy and Angiogenesis in Hibernating Myocardium
Vatner, S. F. (2005) · Circulation Research · doi:10.1161/01.res.0000164184.63158.6c · Cited by 33
Schotten, U., Konigs, B., Rueppel, M., Schöndube, F. A., Bokník, P., Schmitz, W. L., & Hanrath, P. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.0981 · Cited by 32
Laredo, R., Monserrat, L., Hermida‐Prieto, M., Fernández, X., Rodrı́guez, I., Cazón, L., Alvariño, I., Dumont, C. A., Piñón-Esteban, P., Peteiro, J., et al. (2006) · Revista Española de Cardiología · doi:10.1157/13093977 · Cited by 28
Cited by
Induced Pluripotent Stem Cells and Their Use in Human Models of Disease and Development
Karagiannis, P., Takahashi, K., Saito, M., Yoshida, Y., Okita, K., Watanabe, A., Inoue, H., Yamashita, J. K., Todani, M., Nakagawa, M., et al. (2019) · Physiological Reviews · doi:10.1152/physrev.00039.2017 · Cited by 368
Denning, C., Borgdorff, V., Crutchley, J., Firth, K. S. A., George, V., Kalra, S., Kondrashov, A., Hoang, M. D., Mosqueira, D., Patel, A., et al. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2015.10.014 · Cited by 293
“Thus, dantrolene abolished isoprenaline-induced arrhythmias in CPVT1 hiPSC-CMs [58], while trichostatin A was shown to prevent hypertrophy in HCM hiPSC-CMs [64].”
BackgroundInfluentialPrecise correction of Duchenne muscular dystrophy exon deletion mutations by base and prime editing
Chemello, F., Chai, A. C., Li, H., Rodriguez-Caycedo, C., Sanchez-Ortiz, E., Atmanli, A., Mireault, A. A., Liu, N., Bassel-Duby, R., & Olson, E. N. (2021) · Science Advances · doi:10.1126/sciadv.abg4910 · Cited by 244
Mosqueira, D., Mannhardt, I., Bhagwan, J. R., Lis-Slimak, K., Katili, P., Scott, E., Hassan, M., Prondzynski, M., Harmer, S. C., Tinker, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy249 · Cited by 238
Cardiac myosin-binding protein C (MYBPC3) in cardiac pathophysiology
Carrier, L., Mearini, G., Stathopoulou, K., & Cuello, F. (2015) · Gene · doi:10.1016/j.gene.2015.09.008 · Cited by 230
Metadata
- Authors
- Han, L., Li, Y., Tchao, J., Kaplan, A. D., Lin, B., Li, Y., Mich-Basso, J., Lis, A., Hassan, N., London, B., Bett, G. C. L., Tobita, K., Rasmusson, R. L., & Yang, L.
- Affiliations
- University of Pittsburgh (US)
- University at Buffalo, State University of New York (US)
- University of Iowa (US)
- Corresponding author
- Yang, Lei
- ORCID
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-09-10
- Volume
- 104
- Issue
- 2
- Pages
- 258-269
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- PMC
- PMC4217687
- OpenAlex
- W2149847832
- Cited by
- 191
- References
- 48
- Citations by year
- 2026: 1 · 2025: 8 · 2024: 19 · 2023: 15 · 2022: 13 · 2021: 17 · 2020: 20 · 2019: 17 · 2018: 22 · 2017: 15 · 2016: 22 · 2015: 20 · 2014: 2
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Cardiovascular Research (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- American Heart Association (R21 HL094402, 11SDG5580002)
- University of Pittsburgh (UL1TR000005)
- National Institutes of Health (11SDG5580002, 5r01hl062465-15, UL1TR000005)
- Medical Center, University of Pittsburgh
- National Heart, Lung, and Blood Institute (HL062465, R21HL093631, R21HL094402, HL093631, T32-HL76124, T32HL076124)
- National Center for Advancing Translational Sciences
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- familial hypertrophic cardiomyopathy, induced pluripotent stem cells, MYH7 mutation, sarcomere disorganization, cell proliferation, gene expression profiling, disease mechanisms, personalized treatment, inherited heart disease
- MeSH terms
- Cellular Reprogramming Techniques, Action Potentials, Adult, Animals, Cell Separation, Cells, Cultured, Female, Gene Expression Regulation, Humans, Phenotype, Sarcomeres, Case-Control Studies, Mice, SCID, Mice, Inbred NOD, Myosin Heavy Chains, Calcium Signaling, Genetic Predisposition to Disease, Gene Expression Profiling, Cardiac Myosins, Cardiomyopathy, Hypertrophic, Familial, Myocytes, Cardiac, Cell Proliferation, Gene Regulatory Networks, Induced Pluripotent Stem Cells, Transcriptome, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.